AI Drug Discovery

AI Drug Discovery

Building Better Medicines with AI

With 192 compounds and 67 validated assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology, we're innovating at the intersection of data science, biology and drug development

With 192 compounds and 67 validated assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology, we're innovating at the intersection of data science, biology and drug development

As Featured In

Model Medicines

Humanity Can’t Wait Decades, Which is Why We Focus on Days

We are focused on discovering drugs with best-in-class potential against rigorous target product profiles, not merely creating thousands of hits that never reach the clinic or pharmacy.

With GALILEO™, we've discovered 192 compounds and advanced 67 assets in cellular models of disease across 12 therapeutic targets for multiple areas of biology. Our data was validated by preeminent researchers and scientists at premier academic and corporate laboratories

News & Events

Apr 1, 2025

Press

Model Medicines Featured on Bloomberg’s Vanguards of Health Care: Transforming Drug Discovery with AI

Apr 1, 2025

Events

Model Medicines CEO Daniel Haders II to Speak at Bloomberg's 4th Annual Generative AI Conference

Mar 20, 2025

Pre-Print

AmesNet: A Deep Learning Model Enhancing Generalization in Ames Mutagenicity Prediction

Mar 18, 2025

Insights

Antivirals: From One Too Many to One-to-Many

Apr 1, 2025

Press

Model Medicines Featured on Bloomberg’s Vanguards of Health Care: Transforming Drug Discovery with AI

Apr 1, 2025

Events

Model Medicines CEO Daniel Haders II to Speak at Bloomberg's 4th Annual Generative AI Conference

Apr 1, 2025

Press

Model Medicines Featured on Bloomberg’s Vanguards of Health Care: Transforming Drug Discovery with AI

Apr 1, 2025

Events

Model Medicines CEO Daniel Haders II to Speak at Bloomberg's 4th Annual Generative AI Conference

PartnershipS

Validated by Leading Scientists at Top Academic and Corporate Labs

Our data is validated by preeminent researchers and scientists at premier academic and corporate laboratories.

We recognize that no one business can revolutionize the way medicines are discovered and developed on their own. We want to leverage our technology and expertise in partnership with the world’s leading researchers and scientists.